Results 211 to 220 of about 47,188 (263)
Efficacy and safety of urate-lowering therapies in asymptomatic hyperuricaemia: a systematic review and network meta-analysis of key clinical outcomes. [PDF]
Ann MedYi Y, Yang J, Chen Y, Liu H, Deng Y.
europepmc +1 more source
Azathioprine co-therapy with allopurinol for inflammatory bowel disease: Trials and tribulations [PDF]
, 2012 Ansari, Azhar R., Duley, John A.
core
Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study. [PDF]
Clin RheumatolMagagnoli J +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Pharmacology & Therapeutics, 1978
A spectrophotometric assay for measuring allopurinol and oxipurinol has been developed which can detect as little as 5 × 10−8 M of each in serum and urine. With this assay, serum disappearance characteristics of intravenous and orally administered allopurinol have been investigated in man.
K, Hande, E, Reed, B, Chabner
openaire +2 more sources
A spectrophotometric assay for measuring allopurinol and oxipurinol has been developed which can detect as little as 5 × 10−8 M of each in serum and urine. With this assay, serum disappearance characteristics of intravenous and orally administered allopurinol have been investigated in man.
K, Hande, E, Reed, B, Chabner
openaire +2 more sources